SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "(L773:1877 8860 OR L773:1877 8879) srt2:(2015-2019)"

Sökning: (L773:1877 8860 OR L773:1877 8879) > (2015-2019)

  • Resultat 1-10 av 93
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Aarnio, Mikko, et al. (författare)
  • Visualization of painful inflammation in patients with pain after traumatic ankle sprain using [(11)C]-D-deprenyl PET/CT.
  • 2017
  • Ingår i: Scandinavian Journal of Pain. - : Walter de Gruyter. - 1877-8860 .- 1877-8879. ; 17:1, s. 418-424
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND AND AIMS: Positron emission tomography (PET) with the radioligand [(11)C]-D-deprenyl has shown increased signal at location of pain in patients with rheumatoid arthritis and chronic whiplash injury. The binding site of [(11)C]-D-deprenyl in peripheral tissues is suggested to be mitochondrial monoamine oxidase in cells engaged in post-traumatic inflammation and tissue repair processes. The association between [(11)C]-D-deprenyl uptake and the transition from acute to chronic pain remain unknown. Further imaging studies of musculoskeletal pain at the molecular level would benefit from establishing a clinical model in a common and well-defined injury in otherwise healthy and drug-naïve subjects. The aim of this study was to investigate if [(11)C]-D-deprenyl uptake would be acutely elevated in unilateral ankle sprain and if tracer uptake would be reduced as a function of healing, and correlated with pain localizations and pain experience.METHODS: Eight otherwise healthy patients with unilateral ankle sprain were recruited at the emergency department. All underwent [(11)C]-D-deprenyl PET/CT in the acute phase, at one month and 6-14 months after injury.RESULTS: Acute [(11)C]-D-deprenyl uptake at the injury site was a factor of 10.7 (range 2.9-37.3) higher than the intact ankle. During healing, [(11)C]-D-deprenyl uptake decreased, but did not normalize until after 11 months. Patients experiencing persistent pain had prolonged [(11)C]-D-deprenyl uptake in painful locations.CONCLUSIONS AND IMPLICATIONS: The data provide further support that [(11)C]-D-deprenyl PET can visualize, quantify and follow processes in peripheral tissue that may relate to soft tissue injuries, inflammation and associated nociceptive signaling. Such an objective correlate would represent a progress in pain research, as well as in clinical pain diagnostics and management.
  •  
2.
  • Andersson, Viveka, et al. (författare)
  • Pain and pain management in hospitalized patients before and after an intervention
  • 2017
  • Ingår i: Scandinavian Journal of Pain. - : Walter de Gruyter GmbH. - 1877-8860 .- 1877-8879. ; 15, s. 22-29
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and aim Studies have shown that pain is common among hospitalized patients and that there is a lack of compliance with pain management guidelines. Improving pain management does not only involve developing new drugs or technology; even more important is an effective organisation that utilises existing expertise. The aim of this study was to investigate whether pain in hospitalized patients can be reduced by implementing evidence-based pain management guidelines, providing education for staff and an organisation that includes pain responsibility nurses. Methods A cross-sectional study was carried out between 2009 and 2010 at two hospitals in southwest Sweden, comprising a baseline survey followed by an intervention. The study involved 306 patients, who answered questions about pain intensity at rest and while moving, disturbed sleep due to pain and whether they had used a pain rating scale while in hospital. Medical records were scrutinised for analgesic prescriptions. An intervention then took place, involving implementation of evidence-based guidelines, staff education and the introduction of pain responsibility nurses. A follow-up survey was carried out in 2012, in which 293 patients answered the same questions and their medical records were also reviewed. The baseline results were then compared with those of the follow-up survey. Results When compared with the baseline survey, the follow-up survey revealed significant differences in the use of validated pain rating instruments as well as the prescription of more appropriate analgesics. Prescription of paracetamol increased significantly in the follow-up survey; 56% of the patients were prescribed paracetamol on a regular basis, compared with 42% at baseline. There was also a significant increase in the use of strong opioids, from 38% at baseline to 55% at follow-up. Prescriptions of weak opioids decreased from 16% at baseline to 4% at follow-up. No significant differences were observed in patient pain levels in the follow-up survey. At baseline, 29% of the patients reported moderate to severe pain at rest (NRS 4–10) and at follow-up that figure was 24% (NRS 4–10). In both surveys, 41% reported moderate to severe pain (NRS 5–10) during movement. Thirty-nine percent reported disturbed sleep at night at both baseline and follow-up. Conclusions This study demonstrates that evidence-based guidelines made accessible to all staff as a pocket size booklet and on the intranet, in combination with staff education, pain responsibility nurses who informed other staff on their own wards, improved the prescription of analgesics in the hospitals studied. In order to achieve a noticeable effect for patients, i.e., reduced pain levels, an intervention containing more components than those employed in the present study is required. Implications Nurses and physicians need greater knowledge about the importance of pain rating. A vital part of pain management at hospitals is continuous evaluation of treatment outcomes to prevent severe pain and disturbed sleep. The complexity of pain and pain management requires commitment, time and knowledge on the part of healthcare staff. Multi-professional pain teams that support ward staff in pain management are necessary in order to reduce suffering and unnecessary pain in hospitalized patients. © 2016 Scandinavian Association for the Study of Pain
  •  
3.
  • Björkman, Berit, et al. (författare)
  • The meaning and consequences of amputation and mastectomy from the perspective of pain and suffering
  • 2017
  • Ingår i: Scandinavian Journal of Pain. - : Elsevier. - 1877-8860 .- 1877-8879. ; 14:1, s. 100-107
  • Tidskriftsartikel (refereegranskat)abstract
    • BackgroundThe concepts ‘pain’ and ‘suffering’ are frequently treated as synonymous. However, they are clearly distinct phenomena. Phantom phenomena including pain and sensory disturbances are still recognized as long-lasting problems after limb amputation and after mastectomy. The complex nature of phantom phenomena makes the interpretation of its results ambiguous, regarding the prevalence of pain, sensory disturbances and the accompanying suffering. There is clinical experience that suffering is a great burden for the individual but there is a lack of systematic studies of patients’ own evaluations of the suffering caused by their phantom phenomena.ObjectivesThe overall aim of this study was to identify and describe patients’ suffering related to, and as a part, of their post-amputation situation.MethodsThe present study constitutes a part of a prospective, two-year follow up project investigating interviews of 28 men and women in different ages and who have undergone a limb amputation or mastectomy. The reason for amputation or mastectomy varied among the patients and included vascular diseases, cancer (sarcoma and breast-cancer) and trauma. Our ambition was to extract as much variations as possible in different, individualized aspects of the actual pain and suffering producing situation. The participants were, here, invited to open-ended, narrative-oriented interviews one month after the surgery. The interviews were transcribed verbatim and analyzed within qualitative methodology: thematic content analysis.ResultsTwenty-two of 28 interviewees experienced phantom pain and phantom sensations. The two surgical processes amputation and mastectomy meant for a majority of the interviewees a critical event with threatening consequences for everyday life such as loss of function and personal integrity. Nine interviewees felt even stigmatized as a result of their lost body part. Numerous inter-related factors following the amputation/mastectomy, which can inflict severe suffering on the amputee, were uncovered. The context in which the interviewees were informed about the decision to amputate proved to be one such critical and important factor.ConclusionTo understand potential suffering in relation to phantom phenomena, it will never be enough merely to have knowledge of the underlying physiological or neurological mechanisms and/or the intensity of phantom pain and phantom sensations. Rather, it is necessary to find out how the loss of the body part and its everyday consequences are experienced by patients.ImplicationsIt is important to create time for real dialogue with the patients both during pre-operative preparation and post-operative rehabilitation in order to clarify and verbalize elements that constitute the patients individual suffering. Hopefully this strategy can alleviate future chronic pain problems, severe psycho-social distress and suffering. Such an approach ought to have impact also for perceived suffering after other types of surgery or different invasive treatments.
  •  
4.
  • Block, Linda (författare)
  • Glial dysfunction and persistent neuropathic postsurgical pain
  • 2016
  • Ingår i: Scandinavian Journal of Pain. - : Walter de Gruyter GmbH. - 1877-8860 .- 1877-8879. ; 10, s. 74-81
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Acute pain in response to injury is an important mechanism that serves to protect living beings from harm. However, persistent pain remaining long after the injury has healed serves no useful purpose and is a disabling condition. Persistent postsurgical pain, which is pain that lasts more than 3 months after surgery, affects 10-50% of patients undergoing elective surgery. Many of these patients are affected by neuropathic pain which is characterised as a pain caused by lesion or disease in the somatosensory nervous system. When established, this type of pain is difficult to treat and new approaches for prevention and treatment are needed. A possible contributing mechanism for the transition from acute physiological pain to persistent pain involves low-grade inflammation in the central nervous system (CNS), glial dysfunction and subsequently an imbalance in the neuron-glial interaction that causes enhanced and prolonged pain transmission. Aim: This topical review aims to highlight the contribution that inflammatory activated glial cell dysfunction may have for the development of persistent pain. Results: Immediately after an injury to a nerve ending in the periphery such as in surgery, the inflammatory cascade is activated and immunocompetent cells migrate to the site of injury. Macrophages infiltrate the injured nerve and cause an inflammatory reaction in the nerve cell. This reaction leads to microglia activation in the central nervous system and the release of pro-inflammatory cytokines that activate and alter astrocyte function. Once the astrocytes and microglia have become activated, they participate in the development, spread, and potentiation of low-grade neuroinflammation. The inflammatory activated glial cells exhibit cellular changes, and their communication to each other and to neurons is altered. This renders neurons more excitable and pain transmission is enhanced and prolonged. Astrocyte dysfunction can be experimentally restored using the combined actions of a mu-opioid receptor agonist, a mu-opioid receptor antagonist, and an anti-epileptic agent. To find these agents we searched the literature for substances with possible anti-inflammatory properties that are usually used for other purposes in medicine. Inflammatory induced glial cell dysfunction is restorable in vitro by a combination of endomorphine-1, ultralow doses of naloxone and levetiracetam. Restoring inflammatory-activated glial cells, thereby restoring astrocyte-neuron interaction has the potential to affect pain transmission in neurons. Conclusion: Surgery causes inflammation at the site of injury. Peripheral nerve injury can cause low-grade inflammation in the CNS known as neuroinflammation. Low-grade neuroinflammation can cause an imbalance in the glial-neuron interaction and communication. This renders neurons more excitable and pain transmission is enhanced and prolonged. Astrocytic dysfunction can be restored in vitro by a combination of endomorphin-1, ultralow doses of naloxone and levetiracetam. This restoration is essential for the interaction between astrocytes and neurons and hence also for modulation of synaptic pain transmission. Implications: Larger studies in clinical settings are needed before these findings can be applied in a clinical context. Potentially, by targeting inflammatory activated glial cells and not only neurons, a new arena for development of pharmacological agents for persistent pain is opened.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Breivik, Harald, et al. (författare)
  • CNS-mechanisms contribute to chronification of pain
  • 2017
  • Ingår i: Scandinavian Journal of Pain. - : Walter de Gruyter GmbH. - 1877-8860 .- 1877-8879. ; 15:1, s. 137-139
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 93
Typ av publikation
tidskriftsartikel (89)
forskningsöversikt (3)
konferensbidrag (1)
Typ av innehåll
refereegranskat (75)
övrigt vetenskapligt/konstnärligt (18)
Författare/redaktör
Linton, Steven J., 1 ... (10)
Gordh, Torsten (8)
Flink, Ida, 1980- (6)
Peterson, Magnus, 19 ... (3)
Taube, Adam (3)
Stålnacke, Britt-Mar ... (3)
visa fler...
Eriksson, Måns, 1986 ... (2)
Sandblom, Gabriel (2)
Nyberg, Fred (2)
Svärdsudd, Kurt, 194 ... (2)
Agreus, L (1)
Fjällskog, Marie Lou ... (1)
Aarnio, Mikko (1)
Sörensen, Jens (1)
Appel, Lieuwe (1)
Fredriksson, Mats (1)
Wolf, Olof (1)
Linnman, Clas (1)
Thulin, M (1)
Magnuson, Anders (1)
Elmståhl, Sölve (1)
Sanmartin Berglund, ... (1)
Enthoven, Paul, 1955 ... (1)
Hansson, Elisabeth, ... (1)
Kristiansson, Per (1)
Larsson, S. (1)
Bergman, Stefan (1)
Skillgate, Eva (1)
Lilje, Stina (1)
Peterson, Anna (1)
Arving, Cecilia (1)
Block, Linda (1)
Simrén, Magnus, 1966 (1)
Carlsson, Sven G., 1 ... (1)
Sundgren, Pia C. (1)
Svensson, Peter (1)
Calvo, M. (1)
Gunnarsson, Ulf (1)
Skiöldebrand, Eva (1)
Anderberg, Peter (1)
Agerström, Jens (1)
Gunnarsson, Helena E ... (1)
Jöud, Anna (1)
Stenfors, C (1)
Björkegren, Karin (1)
Ahlberg, Karin, 1965 (1)
Axelin, Anna (1)
Nordin, Karin (1)
Henoch, Ingela, 1956 (1)
visa färre...
Lärosäte
Uppsala universitet (39)
Örebro universitet (25)
Karolinska Institutet (16)
Göteborgs universitet (9)
Lunds universitet (9)
Linköpings universitet (8)
visa fler...
Umeå universitet (6)
Mittuniversitetet (3)
Karlstads universitet (3)
Malmö universitet (2)
Linnéuniversitetet (2)
Högskolan Dalarna (2)
Sophiahemmet Högskola (2)
Stockholms universitet (1)
Mälardalens universitet (1)
Södertörns högskola (1)
Högskolan i Skövde (1)
Högskolan i Borås (1)
Blekinge Tekniska Högskola (1)
Sveriges Lantbruksuniversitet (1)
Röda Korsets Högskola (1)
visa färre...
Språk
Engelska (93)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (81)
Samhällsvetenskap (23)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy